Platelet And Plasma Market Analysis, Trends, and Forecast by 2031

Coverage: Platelet And Plasma Market covers analysis By : Component (Platelets, Plasma); Application (Hemophilia, Thrombocytopenia, Perioperative indications, Platelet function disorders, Other platelet applications, Coagulation factor deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver disease, Other plasma applications); End User (Hospitals, Ambulatory Surgical Centers, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00017617
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

The Platelet And Plasma Market is expected to register a CAGR of 13% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by component (Platelets, Plasma); Application (Hemophilia, Thrombocytopenia, Perioperative indications, Platelet function disorders, Other platelet applications, Coagulation factor deficiencies, Thrombotic Thrombocytopenic Purpura, Hemorrhage, Liver disease, Other plasma applications), and End User (Hospitals, Ambulatory Surgical Centers, Others). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Platelet And Plasma Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Platelet And Plasma Market Segmentation

Component
  • Platelets
  • Plasma
Application
  • Hemophilia
  • Thrombocytopenia
  • Perioperative indications
  • Platelet function disorders
  • Other platelet applications
  • Coagulation factor deficiencies
  • Thrombotic Thrombocytopenic Purpura
  • Hemorrhage
  • Liver disease
  • Other plasma applications
End User
  • Hospitals
  • Ambulatory Surgical Centers

Strategic Insights

Platelet And Plasma Market Growth Drivers
  • Increase in Sports Injuries Due to Growing Participation in Sporting Events: More people getting involved in sporting events drives market expansion for platelet-rich plasma (PRP). More people taking part in sports means more athletes are getting hurt through their sports activities. More people suffering from sports injuries now seek PRP treatment because this therapy uses natural growth factors from their blood to help damaged tissues heal faster. Athletes everywhere now use PRP treatments because this therapy helps them recover faster and heal better which makes it a top choice in sports medicine. Market analysts predict strong expansion for platelet-rich plasma usage over the next years with most growth happening in sports medicine because of increasing sports injuries. More sports organizations and athletes choose PRP therapy as an effective alternative to invasive treatments for their injuries. The platelet-rich plasma market will expand due to more athletes from different sports using PRP treatments. PRP therapies for sports medicine will attract more patients because athletes and sports organizations recognize PRP works well for their injuries. The platelet-rich plasma market will keep growing because more sports injuries occur worldwide which creates higher demand for PRP treatments.
  • Surge in Cosmetic Surgery Procedures: Platelet-rich plasma (PRP) therapy grows rapidly because doctors use it more often in cosmetic surgery. More patients want PRP treatments for cosmetic needs because these treatments work well for multiple aesthetic procedures. People use PRP treatments because they help their skin look better and they get younger while also making their hair grow faster. Doctors use PRP for its common use in facelift operations and hair restoration procedures with people who have hair loss issues. The number of people getting aesthetic PRP treatments has grown rapidly because they care more about their appearance and wellness. Patients who choose PRP therapy benefit from both minimal invasiveness and low risk compared to standard surgical interventions. Cosmetic surgery companies have taken up PRP treatments in large numbers which shows up in market data and drives up total PRP demand. The market for PRP therapy grows because people seek natural ways to improve their skin and hair without using invasive treatments like Botox and dermal fillers. PRP will lead market growth and grow its market share because more people choose aesthetic treatments.
  • Rising Awareness and Donor Recruitment Programs: The platelet and plasma market grew because people became more aware of blood donation and organizations started special programs to find donors. Governments and non-profit organizations worldwide run public education and advertising programs with incentives to attract more blood donors. These programs help maintain a sufficient supply of blood and plasma which doctors need to save patients who have been injured or have cancer or genetic conditions. New medical facilities and plasma donation centers open worldwide as regions where people used to donate little develop more donor centers. The development of new plasma donation centers will strongly impact the market's growth according to current projections. Public health systems and hospitals now receive better platelets and plasma because they connect directly with donor programs. Plasma-derived product sales grow from these recruitment efforts especially in nations like the US, China, and India because they build plasma centers to serve their communities. Plasma supply is becoming easier to access for medical treatments and research which will support platelet and plasma industry development worldwide.
Platelet And Plasma Market Future Trends
  • Growing Adoption of PRP in Regenerative Medicine: One of the most prominent trends in the platelet and plasma market is the growing adoption of platelet-rich plasma (PRP) in regenerative medicine. PRP receives attention because it helps restore injured tissues faster while enhancing recovery across different medical uses. PRP's medical applications keep increasing because researchers now know better how it regenerates tissues. Research shows that PRP use in regenerative medicine will keep growing because of its easy procedure and proven results in treating tendon problems, damaged joints, and age-related skin concerns. Research shows regenerative medicine interest will boost the future growth of PRP treatment options. Many medical facilities worldwide are now using PRP so its market share will increase mostly in developing countries that are adopting modern medical treatments. Research showing PRP's ability to heal tissues and lower inflammation makes doctors expect it will become essential to medical treatment which boosts market expansion. PRP shows promising results that help patients recover better while making its medical use possible in multiple medical fields.
  • Integration of PRP in Hair Restoration Procedures: Platelet-rich plasma (PRP) hair restoration technology is advancing rapidly as a leading trend in the platelet and plasma market future. Dermatologists now use PRP to help people with androgenic alopecia grow more hair and stop hair loss. The platelet and plasma market will see strong growth in PRP hair restoration treatments over the next years because consumers are learning about PRP hair regrowth success and want to try these treatments. As more people choose non-invasive PRP treatments for hair loss the market for this therapy will keep expanding. The market segment for aesthetic treatments and dermatology will expand because doctors and patients now trust PRP to restore thicker hair. PRP treatment is now combined with hair transplant procedures to help patients grow more hair successfully. Hair loss treatment represents the main market growth sector for platelet and plasma products because they work successfully to fight this condition for both genders. PRP will keep growing as technology advances and more patients seek non-surgical hair treatments for hair restoration.
  • Expansion of Plasma-Derived Therapies for Non-Hematological Disorders: Plasma-derived therapies first served patients with blood-related medical conditions like hemophilia and blood clotting problems. Plasma products are becoming widely accepted for medical treatment of conditions beyond traditional blood disorders. Plasma-derived medical items such as immunoglobulins and clotting factors now treat patients who have autoimmune diseases and other non-hematological medical problems. The market will grow bigger as Biopharma moves its treatments into new medical areas beyond traditional uses. New market research shows that demand for immunoglobulin therapy is rising because doctors use it to treat both autoimmune diseases and neurological conditions especially Guillain-Barré Syndrome. Medical researchers are testing plasma-derived treatments for rare and hard-to-treat diseases to expand market potential. The global plasma product market will expand as more medical professionals trust these treatments for different health problems. Plasma therapies expand their uses beyond hematological conditions which drives growth in the platelet and plasma market.
Platelet And Plasma Market Opportunities
  • Expansion of PRP in Orthopedic Surgery: The growing demand for non-invasive treatments in orthopedic surgery presents a strong growth opportunity for platelet-rich plasma (PRP) therapies. Doctors use PRP therapy instead of traditional surgery to treat joint problems and tendonitis while addressing ligament tears and other orthopedic conditions. Orthopedic surgeons use PRP therapy to boost patient recovery time because its natural healing process and anti-inflammatory effects help damaged tissues. Market predictions show PRP treatment in orthopedics will expand due to healthcare providers including it in their regular medical procedures. The growing number of people with musculoskeletal conditions plus doctors' preference for minimal procedures will drive PRP use in orthopedics. PRP's success in reducing invasive surgeries and speeding up healing drives medical providers to use it more often. The number of clinical studies showing PRP benefits for joint fixing and musculoskeletal healing will make PRP therapy more popular in orthopedic surgery. PRP providers will have better growth chances as they expand their services to serve orthopedic patients in areas where people age faster and get more sports-related injuries.
  • Rising Demand for PRP in Chronic Pain Management: The platelet-rich plasma market has new growth potential because more people want PRP treatment as a pain management option for chronic conditions. Millions of people worldwide suffer from chronic pain which develops from osteoarthritis tendinitis and musculoskeletal disorders. Chronic pain patients face problems with standard medicine and surgery because these treatments have risks and weaknesses. PRP shows promise as a treatment because it helps wounds heal and controls swelling without using drugs or surgery. Market forecasts show PRP treatments for chronic pain will experience substantial growth because more people recognize how effective PRP is in managing pain. People will choose PRP more often as they want pain relief methods that work better and are safer than traditional opioids and other pain medications. Many clinics now use PRP therapy for pain management and research supports its benefits which together will boost PRP's market presence in this sector. PRP therapy will expand its role in pain management as patients choose it more often because it brings strong market expansion potential to orthopedic and pain medicine. This shift towards natural, regenerative treatments will be a key factor in the continued expansion of the PRP market.
  • Increased Adoption of PRP in Veterinary Medicine: The PRP market has an excellent growth potential because more veterinarians now use it in their practices. PRP therapy has gained acceptance as a preferred treatment for animal injuries and conditions including musculoskeletal problems and arthritis in racehorses plus companion animals like dogs and cats. The veterinary industry now adopts PRP treatment because medical research shows it works on animals. The market expects PRP treatments for veterinary patients to grow fast because people worldwide are getting more pets and spending more on animal healthcare. PRP treatments use natural mechanisms to promote animal healing and decrease swelling which makes them a better choice than surgical procedures or prolonged medication use. Animal sports medicine practitioners and veterinarians will need PRP treatments more often because they help animals recover from sports injuries and degenerative conditions while speeding up their healing after surgery. More pet owners now know about PRP treatments so they will start using them more often. The veterinary PRP market growth opportunities let specialized companies sell more PRP products and devices to expand their market reach. The new segment holds good potential for future growth in the platelet and plasma sector.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Platelet And Plasma Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Platelet And Plasma Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Platelet And Plasma Market?

The Platelet And Plasma Market is estimated to witness a CAGR of 13% from 2025 to 2031.

What are the driving factors impacting the Platelet And Plasma Market?

The major factors driving the Platelet And Plasma Market are Increase in Sports Injuries Due to Growing Participation in Sporting Events, Surge in Cosmetic Surgery Procedures, and Rising Awareness and Donor Recruitment Programs.

What are the future trends of the Platelet And Plasma Market?

Future Trends in the Platelet And Plasma Market are Growing Adoption of PRP in Regenerative Medicine, Integration of PRP in Hair Restoration Procedures, and Expansion of Plasma-Derived Therapies for Non-Hematological Disorders.

Which are the leading players in the Platelet And Plasma Market?

Some of the players operating in the market are America's Blood Centers, American Association Of Blood Banks, Blood Centers Of America, Indian Red Cross, European Blood Alliance, Japanese Red Cross, Italian Red Cross, Oneblood, South African Red Cross Society, American Red Cross.

What are the deliverable formats of the Platelet And Plasma Market report?

The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.

What are the options available for the customization of this report?

Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Platelet And Plasma Market - By Component
1.3.2 Platelet And Plasma Market - By Application
1.3.3 Platelet And Plasma Market - By End User
1.3.4 Platelet And Plasma Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PLATELET AND PLASMA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PLATELET AND PLASMA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PLATELET AND PLASMA MARKET - GLOBAL MARKET ANALYSIS
6.1. PLATELET AND PLASMA - GLOBAL MARKET OVERVIEW
6.2. PLATELET AND PLASMA - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PLATELET AND PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - COMPONENT
7.1. OVERVIEW
7.2. COMPONENT MARKET FORECASTS AND ANALYSIS
7.3. PLATELETS
7.3.1. Overview
7.3.2. Platelets Market Forecast and Analysis
7.4. PLASMA
7.4.1. Overview
7.4.2. Plasma Market Forecast and Analysis
8. PLATELET AND PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HEMOPHILIA
8.3.1. Overview
8.3.2. Hemophilia Market Forecast and Analysis
8.4. THROMBOCYTOPENIA
8.4.1. Overview
8.4.2. Thrombocytopenia Market Forecast and Analysis
8.5. PERIOPERATIVE INDICATIONS
8.5.1. Overview
8.5.2. Perioperative indications Market Forecast and Analysis
8.6. PLATELET FUNCTION DISORDERS
8.6.1. Overview
8.6.2. Platelet function disorders Market Forecast and Analysis
8.7. OTHER PLATELET APPLICATIONS
8.7.1. Overview
8.7.2. Other platelet applications Market Forecast and Analysis
8.8. COAGULATION FACTOR DEFICIENCIES
8.8.1. Overview
8.8.2. Coagulation factor deficiencies Market Forecast and Analysis
8.9. THROMBOTIC THROMBOCYTOPENIC PURPURA
8.9.1. Overview
8.9.2. Thrombotic Thrombocytopenic Purpura Market Forecast and Analysis
8.10. HEMORRHAGE
8.10.1. Overview
8.10.2. Hemorrhage Market Forecast and Analysis
8.11. LIVER DISEASE
8.11.1. Overview
8.11.2. Liver disease Market Forecast and Analysis
8.12. OTHER PLASMA APPLICATIONS
8.12.1. Overview
8.12.2. Other plasma applications Market Forecast and Analysis
9. PLATELET AND PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. AMBULATORY SURGICAL CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgical Centers Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. PLATELET AND PLASMA MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Platelet And Plasma Market Overview
10.1.2 North America Platelet And Plasma Market Forecasts and Analysis
10.1.3 North America Platelet And Plasma Market Forecasts and Analysis - By Component
10.1.4 North America Platelet And Plasma Market Forecasts and Analysis - By Application
10.1.5 North America Platelet And Plasma Market Forecasts and Analysis - By End User
10.1.6 North America Platelet And Plasma Market Forecasts and Analysis - By Countries
10.1.6.1 United States Platelet And Plasma Market
10.1.6.1.1 United States Platelet And Plasma Market by Component
10.1.6.1.2 United States Platelet And Plasma Market by Application
10.1.6.1.3 United States Platelet And Plasma Market by End User
10.1.6.2 Canada Platelet And Plasma Market
10.1.6.2.1 Canada Platelet And Plasma Market by Component
10.1.6.2.2 Canada Platelet And Plasma Market by Application
10.1.6.2.3 Canada Platelet And Plasma Market by End User
10.1.6.3 Mexico Platelet And Plasma Market
10.1.6.3.1 Mexico Platelet And Plasma Market by Component
10.1.6.3.2 Mexico Platelet And Plasma Market by Application
10.1.6.3.3 Mexico Platelet And Plasma Market by End User
10.2. EUROPE
10.2.1 Europe Platelet And Plasma Market Overview
10.2.2 Europe Platelet And Plasma Market Forecasts and Analysis
10.2.3 Europe Platelet And Plasma Market Forecasts and Analysis - By Component
10.2.4 Europe Platelet And Plasma Market Forecasts and Analysis - By Application
10.2.5 Europe Platelet And Plasma Market Forecasts and Analysis - By End User
10.2.6 Europe Platelet And Plasma Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Platelet And Plasma Market
10.2.6.1.1 Germany Platelet And Plasma Market by Component
10.2.6.1.2 Germany Platelet And Plasma Market by Application
10.2.6.1.3 Germany Platelet And Plasma Market by End User
10.2.6.2 France Platelet And Plasma Market
10.2.6.2.1 France Platelet And Plasma Market by Component
10.2.6.2.2 France Platelet And Plasma Market by Application
10.2.6.2.3 France Platelet And Plasma Market by End User
10.2.6.3 Italy Platelet And Plasma Market
10.2.6.3.1 Italy Platelet And Plasma Market by Component
10.2.6.3.2 Italy Platelet And Plasma Market by Application
10.2.6.3.3 Italy Platelet And Plasma Market by End User
10.2.6.4 Spain Platelet And Plasma Market
10.2.6.4.1 Spain Platelet And Plasma Market by Component
10.2.6.4.2 Spain Platelet And Plasma Market by Application
10.2.6.4.3 Spain Platelet And Plasma Market by End User
10.2.6.5 United Kingdom Platelet And Plasma Market
10.2.6.5.1 United Kingdom Platelet And Plasma Market by Component
10.2.6.5.2 United Kingdom Platelet And Plasma Market by Application
10.2.6.5.3 United Kingdom Platelet And Plasma Market by End User
10.2.6.6 Rest of Europe Platelet And Plasma Market
10.2.6.6.1 Rest of Europe Platelet And Plasma Market by Component
10.2.6.6.2 Rest of Europe Platelet And Plasma Market by Application
10.2.6.6.3 Rest of Europe Platelet And Plasma Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Platelet And Plasma Market Overview
10.3.2 Asia-Pacific Platelet And Plasma Market Forecasts and Analysis
10.3.3 Asia-Pacific Platelet And Plasma Market Forecasts and Analysis - By Component
10.3.4 Asia-Pacific Platelet And Plasma Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Platelet And Plasma Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Platelet And Plasma Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Platelet And Plasma Market
10.3.6.1.1 Australia Platelet And Plasma Market by Component
10.3.6.1.2 Australia Platelet And Plasma Market by Application
10.3.6.1.3 Australia Platelet And Plasma Market by End User
10.3.6.2 China Platelet And Plasma Market
10.3.6.2.1 China Platelet And Plasma Market by Component
10.3.6.2.2 China Platelet And Plasma Market by Application
10.3.6.2.3 China Platelet And Plasma Market by End User
10.3.6.3 India Platelet And Plasma Market
10.3.6.3.1 India Platelet And Plasma Market by Component
10.3.6.3.2 India Platelet And Plasma Market by Application
10.3.6.3.3 India Platelet And Plasma Market by End User
10.3.6.4 Japan Platelet And Plasma Market
10.3.6.4.1 Japan Platelet And Plasma Market by Component
10.3.6.4.2 Japan Platelet And Plasma Market by Application
10.3.6.4.3 Japan Platelet And Plasma Market by End User
10.3.6.5 South Korea Platelet And Plasma Market
10.3.6.5.1 South Korea Platelet And Plasma Market by Component
10.3.6.5.2 South Korea Platelet And Plasma Market by Application
10.3.6.5.3 South Korea Platelet And Plasma Market by End User
10.3.6.6 Rest of Asia-Pacific Platelet And Plasma Market
10.3.6.6.1 Rest of Asia-Pacific Platelet And Plasma Market by Component
10.3.6.6.2 Rest of Asia-Pacific Platelet And Plasma Market by Application
10.3.6.6.3 Rest of Asia-Pacific Platelet And Plasma Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Platelet And Plasma Market Overview
10.4.2 Middle East and Africa Platelet And Plasma Market Forecasts and Analysis
10.4.3 Middle East and Africa Platelet And Plasma Market Forecasts and Analysis - By Component
10.4.4 Middle East and Africa Platelet And Plasma Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Platelet And Plasma Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Platelet And Plasma Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Platelet And Plasma Market
10.4.6.1.1 South Africa Platelet And Plasma Market by Component
10.4.6.1.2 South Africa Platelet And Plasma Market by Application
10.4.6.1.3 South Africa Platelet And Plasma Market by End User
10.4.6.2 Saudi Arabia Platelet And Plasma Market
10.4.6.2.1 Saudi Arabia Platelet And Plasma Market by Component
10.4.6.2.2 Saudi Arabia Platelet And Plasma Market by Application
10.4.6.2.3 Saudi Arabia Platelet And Plasma Market by End User
10.4.6.3 U.A.E Platelet And Plasma Market
10.4.6.3.1 U.A.E Platelet And Plasma Market by Component
10.4.6.3.2 U.A.E Platelet And Plasma Market by Application
10.4.6.3.3 U.A.E Platelet And Plasma Market by End User
10.4.6.4 Rest of Middle East and Africa Platelet And Plasma Market
10.4.6.4.1 Rest of Middle East and Africa Platelet And Plasma Market by Component
10.4.6.4.2 Rest of Middle East and Africa Platelet And Plasma Market by Application
10.4.6.4.3 Rest of Middle East and Africa Platelet And Plasma Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Platelet And Plasma Market Overview
10.5.2 South and Central America Platelet And Plasma Market Forecasts and Analysis
10.5.3 South and Central America Platelet And Plasma Market Forecasts and Analysis - By Component
10.5.4 South and Central America Platelet And Plasma Market Forecasts and Analysis - By Application
10.5.5 South and Central America Platelet And Plasma Market Forecasts and Analysis - By End User
10.5.6 South and Central America Platelet And Plasma Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Platelet And Plasma Market
10.5.6.1.1 Brazil Platelet And Plasma Market by Component
10.5.6.1.2 Brazil Platelet And Plasma Market by Application
10.5.6.1.3 Brazil Platelet And Plasma Market by End User
10.5.6.2 Argentina Platelet And Plasma Market
10.5.6.2.1 Argentina Platelet And Plasma Market by Component
10.5.6.2.2 Argentina Platelet And Plasma Market by Application
10.5.6.2.3 Argentina Platelet And Plasma Market by End User
10.5.6.3 Rest of South and Central America Platelet And Plasma Market
10.5.6.3.1 Rest of South and Central America Platelet And Plasma Market by Component
10.5.6.3.2 Rest of South and Central America Platelet And Plasma Market by Application
10.5.6.3.3 Rest of South and Central America Platelet And Plasma Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PLATELET AND PLASMA MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PLATELET AND PLASMA MARKET, KEY COMPANY PROFILES
13.1. AMERICA’S BLOOD CENTERS
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AMERICAN ASSOCIATION OF BLOOD BANKS
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BLOOD CENTERS OF AMERICA
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. INDIAN RED CROSS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. EUROPEAN BLOOD ALLIANCE
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. JAPANESE RED CROSS
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ITALIAN RED CROSS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ONEBLOOD, SOUTH AFRICAN RED CROSS SOCIETY
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. AMERICAN RED CROSS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SOUTH AFRICAN RED CROSS SOCIETY
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. America's Blood Centers
2. American Association Of Blood Banks
3. Blood Centers Of America
4. Indian Red Cross
5. European Blood Alliance
6. Japanese Red Cross
7. Italian Red Cross
8. Oneblood
9. South African Red Cross Society
10. American Red Cross

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Platelet And Plasma Market